La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Beijing Leadman BiochemistryLtd Gestione

Gestione criteri di controllo 0/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEO	n/a
Mandato del CEO	no data
Proprietà del CEO	n/a
Durata media del management	Nessun dato
Durata media del Consiglio di amministrazione	2.8yrs

Aggiornamenti recenti sulla gestione

Recent updates

A Look At The Fair Value Of Beijing Leadman Biochemistry Co.,Ltd. (SZSE:300289)

Apr 19

Beijing Leadman Biochemistry Co.,Ltd. (SZSE:300289) Shares Fly 27% But Investors Aren't Buying For Growth

Mar 08

AMMINISTRATORE DELEGATO

Beijing Leadman BiochemistryLtd non ha un CEO, o non abbiamo dati su di loro.

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
Yan Wang	Independent Director	5.6yrs	CN¥120.00k	0.26% CN¥ 5.5m
Yuqing Ouyang	Member of Supervisory Board	5.6yrs	Nessun dato	Nessun dato
Kaixiang Wang	Non-Independent Chairman of the Board	4yrs	Nessun dato	Nessun dato
Yunxin Zheng	Non-Independent Director	2.8yrs	Nessun dato	Nessun dato
Zhenghe Yang	Non-Independent Director	3.4yrs	Nessun dato	Nessun dato
Yanyi Huang	Non-Independent Director	2.8yrs	CN¥180.00k	Nessun dato
Zhiqian Zhang	Independent Director	2.8yrs	CN¥120.00k	Nessun dato
Na An	Independent Director	2.8yrs	CN¥120.00k	Nessun dato
Guan Yu Lin	Chairman of the Supervisory Board	2.8yrs	Nessun dato	Nessun dato

2.8yrs

Durata media

49yo

Età media

Consiglio di amministrazione esperto: Il consiglio di amministrazione di 300289 non è considerato esperto (durata media del mandato 2.8 anni), il che suggerisce un nuovo consiglio.

Beijing Leadman BiochemistryLtd Gestione

Gestione criteri di controllo 0/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

Beijing Leadman Biochemistry Co.,Ltd., Annual General Meeting, Apr 29, 2024

High number of new and inexperienced directors

High number of new and inexperienced directors

High number of new and inexperienced directors

Beijing Leadman Biochemistry Co.,Ltd., Annual General Meeting, Apr 12, 2022

High number of new and inexperienced directors

Recent updates

Second quarter 2024 earnings released: EPS: CN¥0.006 (vs CN¥0.015 in 2Q 2023)

Beijing Leadman Biochemistry Co.,Ltd. to Report First Half, 2024 Results on Aug 17, 2024

First quarter 2024 earnings released: CN¥0.005 loss per share (vs CN¥0.015 profit in 1Q 2023)

A Look At The Fair Value Of Beijing Leadman Biochemistry Co.,Ltd. (SZSE:300289)

Now 20% undervalued after recent price drop

Beijing Leadman Biochemistry Co.,Ltd. to Report Q1, 2024 Results on Apr 26, 2024

Beijing Leadman Biochemistry Co.,Ltd., Annual General Meeting, Apr 29, 2024

Full year 2023 earnings released: EPS: CN¥0.03 (vs CN¥0.10 loss in FY 2022)

Beijing Leadman Biochemistry Co.,Ltd. (SZSE:300289) Shares Fly 27% But Investors Aren't Buying For Growth

Now 21% undervalued after recent price drop

Beijing Leadman Biochemistry Co.,Ltd. to Report Fiscal Year 2023 Results on Mar 28, 2024

Third quarter 2023 earnings released: EPS: CN¥0.013 (vs CN¥0.019 in 3Q 2022)

Beijing Leadman Biochemistry Co.,Ltd. to Report Q3, 2023 Results on Oct 24, 2023

Second quarter 2023 earnings released: EPS: CN¥0.015 (vs CN¥0.022 in 2Q 2022)

Beijing Leadman Biochemistry Co.,Ltd. to Report First Half, 2023 Results on Aug 12, 2023

Full year 2022 earnings released: CN¥0.10 loss per share (vs CN¥0.05 profit in FY 2021)

High number of new and inexperienced directors

Third quarter 2022 earnings released: EPS: CN¥0.019 (vs CN¥0.034 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.022 (vs CN¥0.018 in 2Q 2021)

High number of new and inexperienced directors

First quarter 2022 earnings released: EPS: CN¥0.022 (vs CN¥0.015 in 1Q 2021)

High number of new and inexperienced directors

Beijing Leadman Biochemistry Co.,Ltd. Approves Cash Dividend for the Year 2021

Beijing Leadman Biochemistry Co.,Ltd., Annual General Meeting, Apr 12, 2022

High number of new and inexperienced directors

Third quarter 2021 earnings released: EPS CN¥0.034 (vs CN¥0.026 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.018 (vs CN¥0.023 in 2Q 2020)

Full year 2020 earnings released: CN¥0.12 loss per share (vs CN¥0.016 profit in FY 2019)

Beijing Leadman Biochemistry Co.,Ltd. to Report Fiscal Year 2020 Results on Apr 17, 2021

New 90-day high: CN¥8.19

New 90-day low: CN¥5.86

Beijing Leadman Biochemistry Co.,Ltd. Announces Dismissal of Luo Haobo as a Director

New 90-day low: CN¥6.46

New 90-day low: CN¥6.59

New 90-day high: CN¥8.14

Beijing Leadman Biochemistry Co.,Ltd. (SZSE:300289) signed a share transfer agreement to acquire Shanghai Shangtuo Industrial Co., Ltd. from Shanghai Kelian Commercial Services Center and Wu Fanglin.

New 90-day high - CN¥7.90

Earnings released

Beijing Leadman Biochemistry Co.,Ltd. to Report First Half, 2020 Results on Aug 15, 2020

AMMINISTRATORE DELEGATO

Membri del Consiglio di amministrazione

Durata media

Età media